Can a smartphone app boost chemo adherence in young leukemia patients?
NCT ID NCT03932903
First seen Jan 10, 2026 · Last updated May 19, 2026 · Updated 18 times
Summary
This study is testing a new mobile app that sends timely reminders and support to help teens and young adults (ages 14-29) with acute lymphoblastic leukemia or lymphoma take their oral chemotherapy pills as prescribed. The study enrolls 60 participants who are in the maintenance phase of treatment. The main goal is to see if the app is easy to use and acceptable to patients, not to measure health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.